The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-0880-2023·Announced 2023-07-05

Drug recall: Kanjo homeopathic pain relief cream with arnica due to manufacturing deviations

Homeocare Laboratories recalls Kanjo Homeopathic Pain Relief Cream due to manufacturing process deviations. The recall affects 921 bottles distributed nationwide.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall with no reported illnesses or injuries and a theoretical manufacturing process hazard qualifies as Moderate under the rubric. The recall was voluntarily initiated by the firm.

Plain-English summary

Homeocare Laboratories, Inc. is recalling Kanjo Homeopathic Pain Relief Cream With Arnica (NDC 80551-201-02) due to deviations from current Good Manufacturing Practice (cGMP) standards. The affected product is the 2 oz (56.70G) size with lot number 2446 and an expiration date of March 2024.

The product was distributed nationwide across the United States. A total of 921 bottles were affected by this recall.

Consumers who have purchased this product should stop using it. The recall was voluntarily initiated by the firm on June 5, 2023, and was classified as a Class II recall by the FDA on June 26, 2023. The recall was terminated on September 16, 2024.

The recalled product

Product
Kanjo Homeopathic Pain Relief Cream With Arnica, NET WT 2 oz (56.70G), Manufactured For: Acutens, Inc., Sheridan, WY NDC 80551-201-02
Manufacturer
Homeocare Laboratories, Inc.
Category
Drug — Homeopathic / Topical
Hazard
Affected units
921

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 2446
  • exp. date Mar-24

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 11 recalled by Homeocare Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 11 products in this recall →

Related recalls

Same manufacturer · Homeocare Laboratories, Inc.

See all →

Same hazard · cgmp deviation

See all →

Similar recalls